Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,411.60
(
0.42%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
107.18
(
2.65%
)
Bitcoin
77,639.00
(
1.69%
)
News Focus
News Focus

Replies to post #379857 on Anavex Life Sciences Corp (AVXL)

Replies to #379857 on Anavex Life Sciences Corp (AVXL)
icon url

Investor2014

10/25/22 6:37 AM

#379880 RE: powerwalker #379857

Yes, all the post analysis is exciting from the P2b/3 trial with several more biomarkers being prespecified than previously and lots more not prespecified no doubt including Donepezil.